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Chordin-like 1 (CHRDL1) is a secreted bone morphogenetic protein (BMP) antagonist expressed in
mesenchymal tissues whose function in development of the skeleton has not been examined in detail.
Here we show Chrdl1 is dynamically expressed in the early distal limb bud mesenchyme, with expression
becoming downregulated as development proceeds. Chrdl1 expression is largely excluded from the critical
signaling center of the posterior limb bud, the Zone of Polarizing Activity (ZPA), as has been described for
the BMP antagonist Gremlin (GREM1) (Scherz et al., 2004, Science, 305, 396–399). Unlike Grem1, Chrdl1 is
expressed in the hindlimb by a small subset of ZPA cells and their descendants suggesting divergent
regulation and function between the various BMP antagonists. Ectopic expression of Chrdl1 throughout the
avian limb bud using viral misexpression resulted in an oligodactyly phenotype with loss of digits from the
anterior limb, although the development of more proximal elements of the zeugopod and stylopod were
unaffected. Overgrowths of soft tissue and syndactyly were also observed, resulting from impaired
apoptosis and failure of the anterior mesenchyme to undergo SOX9-dependent chondrogenesis, instead
persisting as an interdigital-like soft tissue phenotype. Sonic hedgehog (SHH) and ﬁbroblast growth factor
(FGF) signaling were upregulated and persisted later in development, however these changes were only
detected late in limb development at timepoints when endogenous Grem1 would normally be down-
regulated and increasing BMP signaling would cause termination of Shh and Fgf expression. Our results
suggest that the early stages of the GREM1–SHH–FGF signaling network are resistant to Chrdl1-over-
expression, leading to normal formation of proximal limb structures, but that later Bmp expression,
impaired by ectopic CHRDL1, is essential for formation of the correct complement of digits.
Published by Elsevier Inc.Introduction
Bone morphogenetic proteins (BMPs) are a family of signaling
molecules with important functions in development and organo-
genesis. In developing skeletal tissues, BMPs regulate diverse
processes such as differentiation of cartilage, muscle and bone,
programmed cell death, and fracture repair (reviewed by Wu et al.,
2007). The potent functions of BMPs are precisely regulated
by extracellular antagonists and agonists, which alter BMPsInc.
spital, Orthopaedic Research
ers Building, Room 270, 300
371.
du (J.M. Allen),
an).
enerative Medicine Institute,
00, Australiabioavailability, as well as by receptor subtypes and intracellular
mediators (reviewed by Ramel and Hill, 2012).
Studies of human genetic disorders and model organisms have
demonstrated that extracellular antagonists of BMP signaling have
critical roles in skeletal development. Noggin-deﬁcient mice have
many developmental abnormalities including joint fusion, carti-
lage overgrowth and impaired somite formation (Brunet et al.,
1998; McMahon et al., 1998; Wijgerde et al., 2005), and mutations
in the NOG gene have been found in several human syndromes
affecting skeletal development including proximal symphalangism
and multiple synostosis (Gong et al., 1999) and brachydactyly type
B2 (Lehmann et al., 2007).
Analysis of mice with impaired GREM1 signaling, either
through targeted inactivation of the Grem1 gene (Khokha et al.,
2003) or mutant limb deformity mouse strains affecting Grem1
expression (Zuniga et al., 2004), have demonstrated that GREM1-
mediated inhibition of BMP signaling is critical for correct main-
tenance and eventual termination of signaling feedback loops
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(SHH), which have essential roles in the outgrowth and patterning
of the limb (reviewed by Bénazet and Zeller, 2009). Limb devel-
opment defects arising from GREM1 deﬁciency can be rescued by
reducing the expression of Bmp4, as demonstrated by crossing
Grem1-null mice onto an allelic series of mutant strains expressing
various levels of Bmp4 (Bénazet et al., 2009). Chordin-null mice
mostly die during embryogenesis or perinatally, exhibiting defects
in the axial and craniofacial skeleton as well as tracheal cartilage
(Bachiller et al., 2003).
Chordin-like 1 (CHRDL1), also known as neuralin-1 (Cofﬁnier
et al., 2001), ventroptin (Sakuta et al., 2001) and neurogenesin-1
(Ueki et al., 2003), is a secreted BMP-binding protein that contains
three von Willebrand type C repeats with homology to chordin
(Nakayama et al., 2001). Direct interaction of CHRDL1 with BMP4
has been demonstrated by several groups, and weaker interactions
with other BMPs and TGF-beta superfamily members have also
been described (Nakayama et al., 2001; Sakuta et al., 2001;
Chandra et al., 2006; Kane et al., 2008). Inhibition of BMP4 activity
by CHRDL1 has been demonstrated in vivo by the ability of
exogenous CHRDL1 to induce secondary axis formation in Xenopus
embryos, which was rescued by co-injection by BMP4 (Nakayama
et al., 2001; Sakuta et al., 2001), and in vitro by antagonizing the
inhibitory effect of BMP4 in angiogenesis assays (Kane et al., 2008).
The modulation of BMP signaling by CHRDL1 has also been
suggested to be dependent on the formation of a ternary complex
with the co-factor Twisted gastrulation, which may inﬂuence the
function of Chrdl1 as either an agonist or antagonist of BMP
signaling (Larman et al., 2009).
CHRDL1 has been well characterized in eye tissues where it is
expressed in a speciﬁc graded pattern along axes of the retina, and
misexpression studies have revealed functions for CHRDL1 in
regional speciﬁcation of retinotectal projection patterns (Sakuta
et al., 2001). Furthermore, mutations or deletion of the CHRDL1
gene in humans have recently been found in patients with
X-linked megalocornea, an abnormality of the anterior segment
of the eye which presents as a deep anterior chamber and a thin
cornea of increased diameter which can lead to mosaic corneal
degeneration and early cataract formation (Webb et al., 2012).
In addition to the retina, Chrdl1 expression has been described
in a diverse range of tissues including limb bud mesenchymal cells
and chondrocytes (Nakayama et al., 2001), however the function of
CHRDL1 in developing skeletal tissues has not been analyzed in
detail. We chose to use the chick limb as a model system for
investigating the function of CHRDL1 since it is readily accessible
to manipulation during embryonic development and has been
used for decades as a model tissue for investigating signaling
pathways important for patterning and development. We report
that Chrdl1 is expressed in limb mesenchyme and in structures
within somites, and that misexpression of Chrdl1 in limbs causes
severe and speciﬁc defects in the development of digits but not in
the development of proximal skeletal structures.Materials and methods
Whole mount in situ hybridization
Probe templates were PCR-ampliﬁed and cloned into the pCR4-
TOPO (Life Technologies) which contains T3 and T7 polymerase
binding sites for transcription of anti-sense and control sense
probes from linearized plasmids. Two independent non-
overlapping riboprobes for Chrdl1 were ampliﬁed using the follow-
ing primer pairs (cChrdl1-1F CTGCCTTTGGGATGATGTCT with
cChrdl1-1R GAAGCTTTGCCTGAAACCTG, and cChrdl1-2F TGGCATCC-
TAATCTCCGGGCCT with cChrdl1-2R CCCCCAGCAGTAACACAGAGCC)and both gave identical staining patterns. Labeled riboprobes were
transcribed using the DIG or FITC RNA labeling mix (Roche) and
puriﬁed using illustra ProbeQuant G-50 micro columns (GE Health-
care). Riboprobes were also generated using constructs for chick Shh
(Riddle et al., 1993), Fgf4 (Niswander et al., 1994), Fgf8 (Crossley
et al., 1996), Grem1 (Capdevila et al., 1999), Msx1 and Msx2 (Robert
et al., 1991), Bmp2 and Bmp4 (Francis et al., 1994), Sox9 (Healy et al.,
1999) and Scleraxis (Scx) (Schweitzer et al., 2001).
Whole mount in situ hybridization for single or dual mRNA
detection was performed as previously described (McGlinn and
Mansﬁeld, 2011). Stained embryos were then photographed using
a Leica MZ-FLIII microscope with a DFC420 camera and Firecam
3.1 software (Leica).
After photography, all virus-injected embryos used for in situ
hybridization were then assayed for injection quality by immunos-
taining for the viral gag antigen using 3C2 monoclonal antibody-
containing hybridoma supernatant (Developmental Studies Hybri-
doma Bank) at 1:5 dilution in DMEM medium containing 10% FCS
and 0.2% Trtion-X100 and developed with the Vectastain Elite ABC
anti-mouse kit (Vector Labs) and SigmaFast DAB tablets (Sigma).
Reported results were observed in at least four virus-infected
limbs and never detected in contralateral uninfected limbs or
control limbs.
TUNEL
For whole mount detection of apoptosis, embryos were ﬁxed,
dehydrated in methanol, digested with proteinase K and then
post-ﬁxed with paraformaldehyde and glutaraldehyde as
described for whole mount in situ hybridization. The In situ Cell
Death Detection AP kit (Roche) reaction mixture was prepared by
adding 1 volume of enzyme solution to 9 volumes of label
solution. Negative control samples were incubated in label solu-
tion without enzyme added. Samples were incubated at 37 1C in
the dark for 1 h, and then washed in PBS overnight at 4 1C. Labeled
apoptotic cells were then detected with 1:5000 alkaline
phosphatase-conjugated anti-FITC Fab fragments (Roche) in PBST
with 1% heat-inactivated sheep serum overnight at 4 1C after
blocking for 1 h in 10% sheep serum. Embryos were then washed
in PBST for 24 h with several changes and detected with BM Purple
(Roche) as described for whole mount in situ hybridization.
RCAS construct preparation
The replication-competent avian sarcoma-leukosis virus long
terminal repeat with splice acceptor (RCAS) retroviral vector
RCAS-Chrdl1 construct was generated by subcloning from an
expression vector in which mouse Chrdl1 was ampliﬁed by RT-
PCR using primers containing EcoRI and XhoI sites and cloned into a
pcDNA3.1 vector (Life Technologies) modiﬁed with an immunoglo-
bulin signal peptide followed by a haemagglutinin (HA) tag (Rhee
et al., 2005). The modiﬁed Chrdl1 sequence containing the vector
signal peptide and tag was ampliﬁed using primers containing SgrAI
sites and a Kozak sequence 5′ to the ATG and were subcloned into
an RCAS-A vector modiﬁed by the insertion of a multiple cloning
site (MCS) containing an SgrAI site (generously provided by Dr
Jimmy Hu). The RCAS-Nog vector was made by RT-PCR from chick
embryo cDNA using the following primers containing SgrAI and
NotI sites, cNog-F TAGCCACCGGTGACCATGGATCATTCCCAGTGCCTTG
and cNog-R TCGAGCGGCCGCCTAGCAGGAGCACTTGCACTC, and sub-
cloned into the MCS-containing RCAS-A vector.
RCAS injection of chick embryos
RCAS-Chrdl1, RCAS-Nog and RCAS-GFP virus were produced as
previously described (Logan and Tabin, 1998). Eggs were incubated
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Fig. 1. Expression of Chrdl1 in limbs and somites during chick embryonic development. (A) At Hamburger–Hamilton (HH) stage 19, Chrdl1 expression is ﬁrst detected in
the developing forelimb (arrow) and hindlimb (arrowhead) buds. (B) At stage 20, Chrdl1 is strongly expressed in the forelimb (ﬂ) and hindlimb (hl) buds, branchial arches
(arrow) and in the somites (s). (C) Later at stage 24 Chrdl1 is also expressed in the forebrain (arrowhead), ventral retina (asterisk) and the somite ventrolateral lip (arrow).
(D–F) Through stages 20–24, Chrdl1 is expressed in the distal mesenchyme of the limb bud (arrowhead) as well as superﬁcial mesenchymal cells that form two stripes along
the limb as development progresses (arrows). (G) Sections through the limb at stage 23 reveal that the domains of distal mesenchymal cells (arrowhead) and the more sparse
mesenchymal cells along the limb (arrow) are located just below the ectoderm, and notably the distal mesenchymal expression is directly adjacent to, but excluded from, the
apical ectodermal ridge (asterisk). (H) At stage 28, Chrdl1 is expressed in superﬁcial mesenchyme (arrow), in the interdigital tissue adjacent to the digits (asterisk) as well as
in the phalanx-forming region (arrowheads) at the tips of the digits. (I–J) In the somites, Chrdl1 is expressed in the myotome (arrowhead) as well as the dorsomedial lip
(arrow). Dashed white line in I indicates the region sectioned in J. Bar; 1 mm (A, B), 2 mm (C), 0.5 mm (D, F, H, I), 50 μm (E), 0.25 mm (G).
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aspiration before virus injection. Aliquots of RCAS virus, containing
0.025% sterile Fast Green as a tracking dye, were loaded into pulled
glass capillary needles and injected into the right lateral plate
mesoderm of Hamburger and Hamilton (1951) stage 9–11 embryos
using a direct displacement apparatus and micromanipulator
(Logan and Tabin, 1998). Control embryos were injected with
RCAS-GFP to control for the injection procedure and to observe
quality of infection.
Bead implantation
Affygel beads (BioRad) were soaked in 0.1 mg/ml recombinant
mouse BMP4 (R&D Systems) overnight at 4 1C. Eggs incubated to
HH stage 22 were windowed to expose the embryo and a BMP4
bead or PBS control was implanted into the limb mesenchyme. The
eggs were re-sealed with tape and incubated at 38 1C for a further
6 h before dissection and processing for whole mount in situ
hybridization.
Skeletal staining
Staining of skeletal tissues with Alcian Blue and Alizarin Red
was performed as previously described (McLeod, 1980). Skeletal
preparations in 100% glycerol were photographed using a Leica
MZ-FLIII microscope with a DFC420 camera and Firecam 3.1 soft-
ware (Leica).Results
Chrdl1 is expressed in early limb and somite development
The expression of Chrdl1 in the developing chick embryo was
analyzed by in situ hybridization. From HH stage 19, Chrdl1 is
strongly expressed in the limb bud mesenchyme (Fig. 1A–G), with
expression also in the somites, eye, and branchial arches (Fig. 1B
and C). In the limb bud, Chrdl1 is expressed in two distinct
domains visualized from stages 20–24 (Fig. 1D–G). A broad domain
is ﬁrst observed throughout the limb mesenchyme extending to
the distal tip, predominantly posteriorly biased, but largely
excluded from the posterior ZPA. In addition, from stage 20 Chrdl1forelimb hindli
H
H
 s
ta
ge
 2
2
H
H
 s
ta
ge
 2
5
Shh
Shh
Chrdl1
Chrdl1
Fig. 2. Chrdl1 expression in the posterior hindlimb bud overlaps with the ZPA. Chrdl1
(A, C) and the distance between these domains increases during development (compare
hindlimb (B, D, F; arrowhead), there is overlap of the Chrdl1- and Shh-expressing domais expressed by sparse cells in the superﬁcial mesenchyme that
form two stripes along the anterior and posterior limb as devel-
opment progresses (Fig. 1D–F). These cells co-localize with a
subset of Pax3-expressing cells (Supplementary Fig. 1), suggesting
that Chrdl1 may also be expressed by myogenic progenitors.
Consistent with this, sections through somites reveal that Chrdl1
is expressed in the myotome and at the sites of the dorsomedial
and ventrolateral lips of the maturing somite (Fig. 1I–J). At later
developmental stages (Fig. 1H), expression of Chrdl1 in the limb is
signiﬁcantly downregulated, though expression is detected in the
interdigital mesenchyme and at the digit tips in the phalanx-
forming region, a region where quantitative regulation of BMP
activity has been suggested to dictate digit identity (Suzuki et al.,
2008).
Regulation of Chrdl1 expression
The strong expression of Chrdl1 in the posterior distal limb bud
mesenchyme and its general exclusion from the ZPA looks broadly
similar to that of Grem1 (Merino et al., 1999), a BMP antagonist
critical for limb development (Khokha et al., 2003). Exclusion of
Grem1 from the ZPA and importantly from all cells descendant
from this signaling center (Fig. 2E), is critical for the timely
downregulation of the SHH–FGF feedback loop and ultimately size
regulation of the autopod (Scherz et al., 2004). To determine if
Chrdl1 expression is regulated by similar mechanisms as Grem1,
we performed dual-color in situ hybridization for Shh and Chrdl1
across various stages of limb development (Fig. 2A–D, F). In the
forelimb, non-overlapping expression is observed for Shh and
Chrd1 at all stages, with a zone of exclusion between the ZPA
and Chrdl1-expressing cells widening over time (Fig. 2C compared
to 2A). While this also holds true at stage 22 in the hindlimb
(Fig. 2B), there is limited separation of the two expression domains
over time, and moreover, at later stages of development a
population of cells express both Chrdl1 and Shh (Fig. 2D and F)
indicating that, in contrast to Grem1, some hindlimb ZPA cells and
their descendants are able to express Chrdl1.
BMPs have been demonstrated to be necessary and sufﬁcient to
induce expression of Grem1 and Nog, a mechanism whereby induc-
tion of an antagonist can regulate the levels of BMP activity
(Capdevila et al., 1999; Gazzerro et al., 1998; Nissim et al., 2006).
To investigate whether Chrdl1 undergoes similar regulation, wemb
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expression in the forelimb bud does not overlap with that of Shh in the forelimb bud
A with C; arrowhead), suggesting similar regulation as Grem1 (E). However in the
ins. Bar; 0.5 mm (A–E), 100 μm (F).
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proximal limb bud normally devoid of Chrdl1 expression and could
demonstrate that Chrdl1 is induced by BMP4 (Fig. 3A and B; n¼4/5).
Furthermore, we observed that Chrdl1 expression was strongly
downregulated in chick limbs in which BMP signaling was reduced
by infection with RCAS-Nog virus (Fig. 3C and D; n¼3/3), providing
further evidence that Chrdl1 expression is induced by BMPs.
Chrdl1-overexpression induces abnormalities of the autopod through
inhibition of programmed cell death and overgrowth of soft tissues
To elucidate the in vivo activity of CHRDL1 during limb devel-
opment, we ectopically expressed Chrdl1 in developing chick
embryos using an RCAS viral expression system. For each micro-
injection, the right side lateral plate mesoderm of the embryo was
selectively targeted, such that the contralateral uninjected side
could serve as an internal negative control. Additional embryos
were injected with RCAS-GFP to control for any effects of the
microinjection procedure and viral infection (not shown).
The autopod of RCAS-Chrdl1 injected limbs were expanded
along the anterior-posterior axis (Fig. 4A–D). Ectopic soft tissue
outgrowths were also detected projecting from Chrdl1-overexpres-
sing limbs (arrowhead in Fig. 4A). Apoptosis was decreased in
RCAS-Chrdl1 injected limbs along the apical ectodermal ridge
(AER) and in the anterior and posterior necrotic zones (Fig. 4C
and D) which have important roles in shaping the developing limb
(Fernández-Terán et al., 2006). RCAS-Chrdl1 injected limbs also
displayed syndactyly, the abnormal fusion of digits by soft tissue
(Fig. 4E), as well as impairments in digit development (see below).
In contrast to previous models of BMP perturbation displaying
dorsal-ventral patterning defects (reviewed by Robert, 2007),
expression of the dorsalizing factor Lmx1b remained restricted to
the dorsal mesoderm in RCAS-Chrdl1 infected limbs and its
domain of expression was not altered (data not shown).
Chrdl1 misexpression causes defects in digit development
Alcian blue and Alizarin red-stained skeletal preparations of
RCAS-Chrdl1-infected chick embryos revealed a severe oligodactylyB
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Fig. 3. Chrdl1 expression is induced by BMP signaling. Implantation of a bead soaked
negative for expression in contralateral control limbs with no bead (B; arrowhead).
expression (C, D). Bar; 0.5 mm (A–D).phenotype primarily affecting the anterior digits (Fig. 5B and D).
Notably, the more proximal limb structures of the stylopod (humerus,
femur) and zeugopod (radius, ulna, tibia, ﬁbula) developed normally
and were indistinguishable between infected and uninfected tissues
(Fig. 5A–D). The severity of the oligodactyly varied between embryos
but most commonly included formation of a single posterior forelimb
digit and, in the hindlimb, formation of only one or two posterior
digits with reduced numbers of phalanges and truncation of one or
two anterior tarsometatarsals at the diaphysis. Analysis of the reduc-
tion in skeletal elements (Table 1) was performed on the hindlimb,
which has greater numbers of digits and phalanges than the forelimb
in chick, giving a better quantitative readout of the phenotype.
Chrdl1-misexpression upregulates the SHH-FGF feedback loop
The expression of key components of the SHH–FGF feedback loop
critical for growth and patterning of the developing limb were
analyzed in RCAS-Chrdl1 injected limbs. No changes in the intensity
or domain of expression of Shh, Fgf4, Fgf8 or Grem1 were detected
prior to stage 25 (data not shown), which is in contrast to what has
been described for RCAS-mediated misexpression of Grem1 (Capdevila
et al., 1999) or Nog (Pizette and Niswander, 1999; Pizette et al., 2001).
However, the expression of Fgf4 (n¼10/14) and Fgf8 (n¼6/10) was
upregulated in Chrdl1-overexpressing limbs at stage 25 (Fig. 6A and C;
blue arrows;) compared to contralateral uninjected control limbs
(Fig. 6B and C; black arrows), and the domain of expression was
expanded anteriorly. Shh expression was also increased in RCAS-
Chrdl1 injected limbs (Fig. 6D; blue asterisk; n¼10/14), whereas no
consistent changes in Grem1 expression were detected (n¼6). Exam-
ination of later timepoints demonstrated that Fgfs continue to be
expressed by AER cells in Chrdl1-overexpressing limbs at stage 28,
whereas their expression is downregulated and barely detectable in
uninjected limbs (Fig. 6E compared to F; n¼6/6).
Chrdl1-overexpression alters expression of genes downstream of
BMPs
A potential early anterior patterning defect underlying the digit
loss in Chrdl1-misexpressing limbs was examined by in situno
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Fig. 4. Abnormalities of autopodial development induced by viral misexpression of Chrdl1. Misexpression of Chrdl1 caused anterior-posterior overgrowth of the autopod
and abnormal soft tissue outgrowths (A; arrowhead). Reduced levels of apoptosis, detected by TUNEL assay (blue) were detected in the AER (C,D; arrowheads) as well as in
the anterior and posterior necrotic zones (C, D; brackets). Interdigital webbing persisted in RCAS-Chrdl1 infected limbs (E; arrowheads) and anterior digits were truncated or
absent (E; digits labeled I–IV). Bar; 0.5 mm (A–D), 1 mm (E).
J.M. Allen et al. / Developmental Biology 381 (2013) 159–169164hybridization analysis of the anterior limb markers Alx4 and Pax9,
and the digit patterning factors Gli3, Hoxd12 or Hoxd13 but no
differences from uninfected limbs were detected (data not shown).
Since CHRDL1 is a putative BMP antagonist, we examined the
expression of the BMP target genes Msx1 and Msx2 in response to
Chrdl1-overexpression. In RCAS-Chrdl1 injected limbs, Msx1 was
ectopically expressed at sites where anterior digits would nor-
mally develop (Fig. 7A; bracket; n¼8/10), whereas in control
tissues Msx1 was predominantly expressed in the interdigital
mesenchyme at HH stage 31 and excluded from sites of digit
formation (Fig. 7A′). However, the intensity of Msx1 expression
detected by in situ hybridization was not affected by Chrdl1-
overexpression. Msx2 was also found to be expressed ectopically
in mesenchymal regions that have failed to differentiate to formdigits (Fig. 7B; bracket and arrowhead; n¼9/12), and levels of
Msx2 were downregulated compared to contralateral untreated
limbs (Fig. 7B and B′).
The expanded autopod of RCAS-Chrdl1 injected limbs fails to
form several skeletal elements, therefore we examined the expres-
sion of the transcription factor Sox9, a master regulator of
chondrogenesis. Consistent with the loss of anterior digits
observed in skeletal preparations, Sox9 was not detected at the
expected sites of the digital rays in the anterior limb after infection
of the limb with RCAS-Chrdl1 virus (Fig. 7C and C′; n¼7/12).
However, a dispersed ectopic Sox9 hybridization signal was
detected in the distal limb mesenchyme that has not condensed
to form a digit (Fig. 7C; asterisk), consistent with previous studies
whereby inhibition of Bmp signaling by Nog-misexpression
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Fig. 5. Misexpression of Chrdl1 causes loss or truncation of anterior digits. Alcian Blue (cartilage) and Alizarin Red (bone)-stained skeletal preparations demonstrate loss
of digits, primarily affecting the anterior limb, in RCAS-Chrdl1 infected limbs (B, D) compared to contralateral uninfected control limbs (A, C). Truncated digits are labeled
with an asterisk. In these representative examples, digits II and III of the forelimb fail to develop whereas the distal phalanx of digit IV is missing (B compared to A). In the
hindlimb, digit I is absent, digits II and III are truncated at mid-tarsometatarsus (TM) and digit IV has formed only two rather than ﬁve phalanges (D compared to C). The
radius (R), ulna (U), humerus (H), tibia (T), ﬁbula and femur (not shown) were morphologically indistinguishable between infected and non-infected limbs. Bar; 2 mm A–D.
Table 1
Quantitation of hindlimb defects in chick embryos whose right lateral plate mesoderm was infected with RCAS-Chrdl1 or RCAS-GFP control virus.
Hindlimb phenotype scoring RCAS-Chrdl1 RCAS-GFP
Right Left Right Left
Unaffected 3/35 31/35 5/5 5/5
Mild Loss of 1–2 distal phalanges 6/35 2/35 0/5 0/5
Moderate Loss of 42 phalanges, tarsometatarsals unaffected 6/35 1/35 0/5 0/5
Severe Loss of multiple skeletal elements including loss/truncation of tarsometatarsal(s) 20/35 1/35 0/5 0/5
J.M. Allen et al. / Developmental Biology 381 (2013) 159–169 165(Pizette and Niswander, 2000) or Smad4 disruption (Bénazet et al.,
2012) also resulted in diffuse, ectopic expression of Sox9 and
Col2a1 but, since cell aggregation and condensation were inhib-
ited, digit formation could not proceed.
Expression of the tendon progenitor marker Scleraxis (Scx)
has been shown to be impaired by BMPs and upregulated
by antagonism of Bmp signaling (Schweitzer et al., 2001). In
Chrdl1-overexpressing limbs, the loss or truncation of digit rays
is accompanied by a loss of associated Scx expression (Fig. 7D and
D′; n¼4/6). However a broad increase in Scx expression was
detected in the distal uncondensed limb mesenchyme (Fig. 7D;
asterisk), consistent with previous results that BMP antagonism by
Nog can induce Scx expression (Schweitzer et al., 2001). The
pattern of Scx expression in the zeugopod appeared normal,
suggesting that development of tendons proximal to the autopod
was unaffected by Chrdl1 misexpression.
BMP proteins have been shown to negatively regulate the
expression of Bmp genes through an auto-regulatory loop (Bastida
et al., 2009). We examined if inhibiting BMP signaling by over-
expressing Chrdl1would impair the ability of BMPs to auto-regulate
their own expression. Bmp2 (n¼9/10) and Bmp4 (n¼5/8) were both
upregulated at the mRNA level in RCAS-Chrdl1 injected limbs
(Fig. 7E-F′), Bmp2 expression was increased particularly in theposterior limb (Fig. 7E; dashed bracket) whereas there was a region
of strong Bmp4 expression (Fig. 7F; black bracket) underlying the
AER in infected limbs only. These data suggest that the ability of
BMP proteins to negatively regulate the expression of Bmp genes
has been impaired.Discussion
We investigated the expression and activity of CHRDL1 during
skeletal development. Chrdl1 is dynamically expressed during limb
development, with broad expression in the limb bud mesenchyme
at early embryonic stages, later becoming restricted to the inter-
digital mesenchyme and the distal tips of developing digits. Chrdl1
expression was regulated by BMP levels in the limb bud. Reduction
in BMP signaling by Nog misexpression strongly downregulated
Chrdl1, and conversely implantation of beads soaked in BMP4
protein stimulated Chrdl1 expression suggesting that, like Nog
(Merino et al., 1998) and Grem1 (Capdevila et al., 1999; Nissim
et al., 2006), Chrdl1 is induced by BMPs to ﬁne tune the levels of
BMP signaling. Increased transcription of Bmps were detected in
Chrdl1-overexpressing limbs, consistent with inhibition of a nega-
tive auto-regulatory feedback loop whereby BMP proteins can
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Fig. 6. Upregulation of the SHH–FGF feedback loop in Chrdl1-overexpressing limbs. Fgf8 and Fgf4 expression was more intense and extended further along the anterior
limb in Chrdl1-overexpressing forelimbs (A, C; blue arrows) compared to control limbs (B, C; black arrows) at HH stage 25. Shh was also strongly upregulated in RCAS-Chrdl1
injected limbs (D; blue asterisk) compared to controls (D; black asterisk). Fgf8 expression also was detected at later timepoints in Chrdl1-overexpressing limbs (E) than in
control limbs (F). No reproducible changes in Grem1 expression were detected. Bar; 0.5 mm (A–D), 1 mm (E–F).
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Shh were also upregulated by Chrdl1-overexpression, which can
also positively regulate Bmp expression (Bastida et al., 2009).
Chrdl1-misexpression also resulted in downregulation of the
BMP target gene Msx2 demonstrating that although Bmp tran-
scription was increased, overall BMP activity was reduced. No
decrease in Msx1 was detected, however several other models
have also demonstrated that Msx2 displays a greater sensitivity to
manipulated BMP signaling than does Msx1 (Khokha et al., 2003;
Pizette and Niswander, 1999). Chrdl1 expression was mostly absent
from the ZPA signaling region of the posterior limb bud, which
prompted us to examine whether, like the BMP antagonist Grem1
(Scherz et al., 2004), the ZPA cells and their descendants are
refractory to Chrdl1 expression. We found that a subset of
hindlimb ZPA cells express both Shh and Chrdl1, and that the
ZPA descendants are therefore not refractory to Chrdl1, suggesting
differences in regulation and function of BMP antagonists in limb
development.
Ectopic overexpression of Chrdl1 in developing chick limbs had
a strikingly speciﬁc effect in impairing development of the
autopod skeleton but with no detectable effect on the formation
of more proximal skeletal elements. Additional phenotypes we
observed, including digit truncations, syndactyly, soft tissue over-
growths, impaired apoptosis and AER expansion, have been
reported in other models of BMP dysregulation, such as misex-
pression of Nog (Guha et al., 2002; Pizette and Niswander, 1999,
2000; Wang et al., 2004) or Grem1 (Capdevila et al., 1999; Merino
et al., 1999), overexpression of a dominant negative form of theBMP receptor 1b (Zou and Niswander, 1996), or disruption of
intracellular BMP signal transduction (Bénazet et al., 2012).
Together, these data provide further conﬁrmation that CHRDL1
also functions in vivo as a BMP antagonist and highlights the
requirement for multiple BMP antagonists in exquisitely shaping
limb formation.
In contrast to the autopod-speciﬁc phenotype observed with
Chrdl1-misexpression, retroviral-mediated misexpression of
Grem1 (Capdevila et al., 1999) in chick limbs caused abnormal
morphogenesis of zeugopodial as well as autopodial elements,
whereas similar experiments with Nog (Pizette and Niswander,
2000) resulted in agenesis of limb skeletal elements. Grem1
misexpression was described as having a biphasic effect in which
early changes reinforcing AER and SHH signaling and limb out-
growth are aberrantly increased, along with the distally expressed
homeobox transcription factor Hoxd13, and then prematurely
downregulated, which may contribute to the severity of the
dysmorphologies and distal truncations (Capdevila et al., 1999).
In contrast, no changes in Hoxd13 expression were detected in
Chrdl1-overexpressing limbs (data not shown), and alterations to
SHH–FGF signaling were not observed prior to HH stage 25,
suggesting that high levels of Chrdl1 misexpression at early time-
points are tolerated without altering SHH–FGF signaling, likely due
to robust compensation by components of the signaling network
at those stages (Bénazet et al., 2009; Lopez-Rios et al., 2012). It has
been recently demonstrated in mice that disrupting BMP signal
transduction in the developing autopod using Hoxa13-cre
mediated Smad4 deletion results speciﬁcally in loss of skeletal
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Fig. 7. Chrdl1-overexpression alters expression of genes downstream of BMPs. Msx1 and Msx2 were strongly expressed in the interdigital mesenchyme in uninjected
limbs at HH stage 31 (A′, B′) but in RCAS-Chrdl1 infected tissues expression was also detected throughout the anterior autopod where digits would normally develop (bracket
in A, B) or where digits appear truncated (arrowhead in B).Msx2was also expressed at lower levels in RCAS-Chrdl1 infected limbs (compare B with B'). Sox9was expressed in
the digit rays at HH stage 27 in control limbs (C′; arrowheads). In Chrdl1-misexpressing limbs, Sox9 was only detected in the primordium of digit 4 (C; arrowhead), but
diffuse expression was also present in the anterior and distal mesenchyme (C; asterisk). Scx expression strongly labeled the digits (D′; arrowheads) as well as developing
tendons of the zeugopod (D′; z) in control limbs. Only a truncated digit 4 in the RCAS-Chrdl1 infected autopod was labeled by Scx hybridization (D; arrowhead) and sites of
ectopic expression were detected in the distal and posterior limb (D; asterisk), whereas the morphology of the zeugopodial tendons (D; z) were unaffected. Bmp2 and Bmp4
were upregulated in the autopod of RCAS-Chrdl1 infected limbs, with higher Bmp2 in the posterior autopod (E; bracket compared to E′) and Bmp4 in the distal mesenchyme
below the AER (F; bracket compared to F′). Bar; 0.5 mm (A–F′).
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more sensitive to either lower levels or earlier loss of Smad4-
mediated BMP signal disruption (Bénazet et al., 2012). Endogenous
Chrdl1 expression is signiﬁcantly downregulated in the distal limb
mesenchyme at stage 28 as the SHH–FGF feedback loop is
terminating and the process of chondrogenic differentiation is
initiating in the autopod. Chrdl1 expression was also absent from
the sites of digit formation in stage 31 limbs suggesting that
inhibition of BMP signaling by CHRDL1 must be relieved for digit
development to occur.
Chrdl1 overexpression led to increased SHH and FGF signaling,
detected as stronger in situ hybridization signals and broadened
expression domains, as well as later persistence of FGF signaling
from the AER. BMPs are known to negatively regulate expression
of these signaling networks (Khokha et al., 2003; Zuniga et al.,
1999) which, although critical for the growth and patterning of the
limb, must be appropriately terminated to allow differentiation of
skeletal tissues. In particular FGFs are essential for stimulating
proliferation of limb bud mesenchymal cells and, along with Wnts,
act to maintain them in an undifferentiated state (ten Berge et al.,
2008). A potential function for FGF/Wnt signaling is to coordinate
proliferation until the limb reaches the appropriate size and shape,
such that cells within the limb bud outside the range of these
‘differentiation-inhibiting’ signals can then differentiate to form
tissues such as cartilage (ten Berge et al., 2008). Chrdl1 over-
expression prevented the BMP-mediated inhibition of FGF and
SHH signaling, and it is likely that the increased FGF signaling
impairs the exit of mesenchymal cells from a proliferative state to
undergo differentiation to form digits (ten Berge et al., 2008;
Lopez-Rios et al., 2012).Although anterior digits failed to form in Chrdl1-overexpressing
limbs, ectopic broad domains of Sox9 expression were detected in
the anterior mesenchyme of infected limbs, but the Sox9-expres-
sing cells failed to aggregate into condensations. This has pre-
viously been observed in Smad4-deﬁcient autopods (Bénazet et al.,
2012) and in Nog-overexpressing limbs (Pizette and Niswander,
2000) suggesting that although Sox9 may be expressed by cells of
the distal limb bud, this is not sufﬁcient to drive the cell aggrega-
tion and mesenchymal condensation, which are required for
chondrogenesis, in the absence of BMP signaling (Bénazet et al.,
2012; Pizette and Niswander, 2000; Zeng et al., 2002). Ectopic Scx
expression in the anterior mesenchyme of Chrdl1-overexpressing
limbs was also diffuse rather than expressed by cells that form a
developing digit structure. Tendon development and maintenance
in the distal limb is highly dependent on the development of the
digits (Hurle et al., 1990; Schweitzer et al., 2010), and Scx expres-
sion and therefore tendon formation is spatially restricted by BMP
signaling from surrounding tissues such as the interdigital
mesenchyme (Schweitzer et al., 2001). This provides a mechanism
whereby RCAS-Chrdl1 misexpression relieving this inhibition
leads to ectopic Scx expression but not necessarily tendon forma-
tion which would require the presence of a digit.
The loss of digits in Chrdl1-misexpressing limbs seems contrary
to studies in mice and humans where gene-deletion and/or
putative loss-of-function mutations that reduce BMP signaling
lead to a polydactyly phenotype (Bakrania et al., 2008; Choi
et al., 2012; Luo et al., 1995; Selever et al., 2004). However, studies
utilizing allelic series of Bmpmutant mice have demonstrated that
reduction in BMP signaling can cause increased AER-FGF signaling,
autopod enlargement and polydactyly, but that further inhibition of
J.M. Allen et al. / Developmental Biology 381 (2013) 159–169168BMPs beyond a certain threshold instead results in loss of skeletal
elements by impairment of chondrogenesis (Bandyopadhyay et al.,
2006; Bénazet et al., 2009). The skeletal malformations in Chrdl1-
misexpressing limbs were restricted only to the autopod, and with
anterior digits affected more severely than posterior digits. This
anterior digit loss is unlikely to be a defect in patterning or anterior
speciﬁcation, since our in situ hybridization studies failed to show any
abnormalities in expression of anterior markers such as Alx4 or Pax9
or genes involved in digit patterning such as Gli3, Hoxd12 or Hoxd13
(data not shown). The strong bias towards loss of anterior digits in
Chrdl1-misexpressing limbs, also observed in mouse limbs deﬁcient in
Smad4-mediated BMP signal transduction (Bénazet et al., 2012), may
reﬂect high levels of BMP activity in the posterior limb due to strong
Bmp2 and Bmp7 expression (Geetha-Loganathan et al., 2006) as well
as increasingly diminished Grem1 expression (Scherz et al., 2004).
Ectopic Grem1 and Nog have been demonstrated to cause severe
limb malformations and truncations by early disruption of the
SHH–FGF loop (Capdevila et al., 1999; Pizette and Niswander, 1999;
Pizette et al., 2001; Zuniga et al., 1999). In contrast, alterations in
SHH–FGF signaling in Chrdl1-misexpressing limbs were only
detected later in limb development (HH stage 25 and later), at a
timepoint when Grem1 expression is normally being downregulated
and increasing Bmp expression would contribute to termination of
SHH–FGF signaling (Bastida et al., 2009; Bénazet et al., 2009; Scherz
et al., 2004; Verheyden and Sun, 2008). These data suggest that the
GREM1–SHH–FGF feedback system is resistant to Chrdl1-overexpres-
sion, but as Grem1 expression is decreasing and the feedback loop
begins terminating, ectopic CHRDL1 is sufﬁcient to prevent BMPs
from downregulating Fgf and Shh expression and from initiating
SOX9-dependent cell condensation and chondrogenesis. The resis-
tance of the GREM1–SHH–FGF network from Chrdl1-overexpression
is unclear, but may result from different ligand speciﬁcity, binding
afﬁnity or protein activities of the highly divergent CHRDL1 and
GREM1, or by the high buffering capacity of the signaling feedback
system (Bénazet et al., 2009). These data illustrate that BMP levels
must be mediated by antagonists for correct outgrowth and pattern-
ing to occur, through a process that is tolerant to Chrdl1-over-
expression, but that later high levels of BMPs are crucial to
formation of the correct complement of digits.Acknowledgements
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